At a glance
- Originator Shionogi
- Class
- Mechanism of Action Endothelin A receptor antagonists; Endothelin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Pulmonary hypertension
Most Recent Events
- 09 Sep 2002 Preclinical trials in Heart failure in Japan (PO)
- 09 Sep 2002 Preclinical trials in Pulmonary hypertension in Japan (PO)
- 17 Feb 2000 Preclinical development for Heart failure in Japan (PO)